-SEC Filing
Gain Therapeutics’ CEO Matthias Alder Issues Letter To Shareholders
Dear Fellow Stockholders,With the start of a new year, I want to take a moment to reflect on Gain's progress over the last 12 months and to share our strategy and plans for 2024.Research and development of pharmaceutical